Precision oncology for ALK positive inflammatory myofibroblastic tumor

Discover Oncology · Published 2026-07-29 · DOI 10.1007/s12672-026-05667-w

Free full text

Authors (2)

Yuyu Yang, Zhenzhen Ma

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Yang, Y., Ma, Z. (2026). Precision oncology for ALK positive inflammatory myofibroblastic tumor. Discover Oncology. https://doi.org/10.1007/s12672-026-05667-w

Related articles

• cGAS-STING pathway-related genes as candidate molecules associated with cervical intraepithelial neoplasia: an exploratory bioinformatics analysis · Discover Oncology · 2026 · Same journal
• Pan-cancer analysis and spatial validation in endometrial cancer reveal CD3D as a prognostic and immunological biomarker · Discover Oncology · 2026 · Same journal
• Systems biology approach to gene network analysis identifies therapeutic and diagnostic targets in colorectal cancer · Discover Oncology · 2026 · Same journal
• FXYD6 functions as a tumor suppressor in lung adenocarcinoma via the OIP5-AS1/miR-4735-3p/FXYD6 axis · Discover Oncology · 2026 · Same journal
• RBM15-mediated ASPM m6A modification facilitates osteosarcoma progression via IGF2BP3-dependent manner · Discover Oncology · 2026 · Same journal
• Differential expression of LYZ across pan-cancer and its prognostic value and immune microenvironment regulatory mechanisms in glioma · Discover Oncology · 2026 · Same journal
• Pan-cancer analysis identifies ODF2 as a dual prognostic and predictive biomarker for immunotherapy · Discover Oncology · 2026 · Same journal
• Ion homeostasis related gene signature characterizes the immune landscape and predicts prognosis in lung adenocarcinoma · Discover Oncology · 2026 · Same journal
• Integrative multi-omics analysis reveals LLPS-associated CLEC2D⁺AR⁻ tumor-cell states linked to early adaptive progression toward castration resistance in prostate cancer · Discover Oncology · 2026 · Same journal
• Global landscape and emerging trends of ubiquitination research in lung cancer based on a bibliometric analysis from 2000 to 2025 · Discover Oncology · 2026 · Same journal